Mechanisms of Probiotics

Handbook of Probiotics and Prebiotics: Second Edition

Volumn , Issue , 2008, Pages 377-440

  Lahtinen, Sampo ^a,b   Ouwehand, Arthur ^b   Collado, M Carmen ^a   Salminen, Seppo ^a   Vesterlund, Satu ^a   Tang, Mimi ^c   Satokari, Reetta ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b Health and Nutrition ^*  (Finland)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Combined probiotics and pathogen adhesion and aggregation; Immune effects of probiotic bacteria; Probiotic mechanisms

Indexed keywords

EID: 84889375222     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470432624.ch5     Document Type: Chapter

References (308)

1. Adlerberth I, Ahrne S, Johansson ML, Molin G, Hanson LA, andWold AE.Amannosespecific adherence mechanism in Lactobacillus plantarum conferring binding to the human colonic cell line HT-29. Appl. Environ. Microbiol. 1996; 62: 2244-2251.
2. Alander M, Korpela R, Saxelin M, Vilpponen-Salmela T, Mattila-Sandholm T, and von Wright A. Recovery of Lactobacillus rhamnosus GG from human colonic biopsies. Lett. Appl. Microbiol. 1997; 24: 61-64.
3. Alander M, Satokari R, Korpela R, Saxelin M, Vilpponen-Salmela T, Mattila-Sandholm T, and von Wright A. Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption. Appl. Environ. Microbiol. 1999; 65: 351-354.
4. Bergonzelli GE, Granato D, Pridmore RD, Marvin-Guy LF, Donnicola D, and Corthesy-Theulaz IE. GroEL of Lactobacillus johnsonii La1 (NCC 533) is cell surface associated: potential role in interactions with the host and the gastric pathogen Helicobacter pylori. Infect. Immun. 2006; 74: 425-434.
5. Bernet MF, Brassart D, Neeser JR, and Servin AL. Adhesion of human bifidobacterial strains to cultured human intestinal epithelial cells and inhibition of enteropathogen-cell interactions. Appl. Environ. Microbiol. 1993; 59: 4121-4128.
6. BernetMF, Brassart D, Neeser JR, and Servin AL. Lactobacillus acidophilusLA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut 1994; 35: 483-489.
7. Bezkorovainy A. Probiotics: determinants of survival and growth in the gut. Am. J. Clin. Nutr. 2001; 73: 399S-405S.
8. Blum S, Reniero R, Schiffrin EJ, Crittenden R, Mattila-Sandholm T, von Wright A, Saarela M, Saxelin M, Collins K, and Morelli L. Adhesion studies for probiotics: need for validation and refinement. Trends Food Sci. Technol. 1999; 10: 405-410.
9. Buck BL, Altermann E, Svingerud T, and Klaenhammer TR. Functional analysis of putative adhesion factors in Lactobacillus acidophilus NCFM. Appl. Environ. Microbiol. 2005; 71: 8344-8351.
10. Cesena C, Morelli L, Alander M, Siljander T, Tuomola E, Salminen S, Mattila-Sandholm T, Vilpponen-Salmela T, and von Wright A. Lactobacillus crispatus and its nonaggregating mutant in human colonization trials. J. Dairy Sci. 2001; 84: 1001-1010.
11. Chauviere G, Coconnier MH, Kerneis S, Darfeuille-Michaud A, Joly B, and Servin AL. Competitive exclusion of diarrheagenic Escherichia coli (ETEC) fromhuman enterocytelike Caco-2 cells by heat-killed Lactobacillus. FEMS Microbiol. Lett. 1992; 70: 213-217.
12. Chauviere G, Coconnier MH, Kerneis S, Fourniat J, and Servin AL. Adhesion of human Lactobacillus acidophilus strain LB to human enterocyte-like Caco-2 cells. J. Gen. Microbiol. 1992; 138(Part 8): 1689-1696.
13. Coconnier MH, Bernet MF, Chauviere G, and Servin AL. Adhering heat-killed human Lactobacillus acidophilus, strain LB, inhibits the process of pathogenicity of diarrhoeagenic bacteria in cultured human intestinal cells. J. Diarrhoeal Dis. Res. 1993; 11: 235-242.
14. Coconnier MH, Klaenhammer TR, Kerneis S, Bernet MF, and Servin AL. Proteinmediated adhesion of Lactobacillus acidophilus BG2FO4 on human enterocyte and mucus-secreting cell lines in culture. Appl. Environ. Microbiol. 1992; 58: 2034-2039.
15. Collado MC, Gueimonde M, Sanz Y, and Salminen S. Adhesion properties and competitive pathogen exclusion ability of bifidobacteria with acquired acid resistance. J. Food Prot. 2006; 69: 1675-1679.
16. Crociani J, Grill JP, Huppert M, and Ballongue J. Adhesion of different bifidobacteria strains to human enterocyte-like Caco-2 cells and comparison with in vivo study. Lett. Appl. Microbiol. 1995; 21: 146-148.
17. Del Re B, Sgorbati B, Miglioli M, and Palenzona D. Adhesion, autoaggregation and hydrophobicity of 13 strains of Bifidobacterium longum. Lett. Appl. Microbiol. 2000; 31: 438-442.
18. Elo S, Saxelin M, and Salminen S. Attachment of Lactobacillus casei strainGGto human colon carcinoma cell line Caco-2: comparison with other dairy strains. Lett. Appl. Microbiol. 1991; 13: 154-156.
19. Frece J, Kos B, Svetec IK, Zgaga Z, Mrsa V, and Suskovic J. Importance of S-layer proteins in probiotic activity of Lactobacillus acidophilus M92. J. Appl. Microbiol. 2005; 98: 285-292.
20. Fuller R and Brooker BE. Lactobacilli which attach to the crop epithelium of the fowl. Am. J. Clin. Nutr. 1974; 27: 1305-1312.
21. Gopal PK, Prasad J, Smart J, and Gill HS. In vitro adherence properties of Lactobacillus rhamnosus DR20 and Bifidobacterium lactis DR10 strains and their antagonistic activity against an enterotoxigenic Escherichia coli. Int. J. Food Microbiol. 2001; 67: 207-216.
22. Granato D, Bergonzelli GE, Pridmore RD, Marvin L, Rouvet M, and Corthesy-Theulaz IE. Cell surface-associated elongation factor Tu mediates the attachment of Lactobacillus johnsonii NCC533 (La1) to human intestinal cells and mucins. Infect. Immun. 2004; 72: 2160-2169.
23. Granato D, Perotti F, Masserey I, Rouvet M, Golliard M, Servin A, and Brassart D. Cell surface-associated lipoteichoic acid acts as an adhesion factor for attachment of Lactobacillus johnsonii La1 to human enterocyte-like Caco-2 cells. Appl. Environ. Microbiol. 1999; 65: 1071-1077.
24. Greene JD and Klaenhammer TR. Factors involved in adherence of lactobacilli to human Caco-2 cells. Appl. Environ. Microbiol. 1994; 60: 4487-4494.
25. Gueimonde M, Noriega L, Margolles A, de los Reyes-Gavilan CG, and Salminen S. Ability of Bifidobacterium strains with acquired resistance to bile to adhere to human intestinal mucus. Int. J. Food Microbiol. 2005; 101: 341-346.
26. Gusils C, Cuozzo S, Sesma F, and Gonzalez S. Examination of adhesive determinants in three species of Lactobacillus isolated from chicken. Can. J. Microbiol. 2002; 48: 34-42.
27. He F, Isolauri E, Morita H, Hosoda M, Hashimoto H, Fuse T, Mizumachi K, Kurisaki J, Benno Y, Salminen S, and Ouwehand AC. Bifidobacteria isolated from allergic and healthy infants: differences in taxonomy, mucus adhesion and immune modulatory effects. Microecol. Ther. 2002; 29: 103-108.
28. He F, Ouwehand AC, Hashimoto H, Isolauri E, Benno Y, and Salminen S. Adhesion of Bifidobacterium spp. to human intestinal mucus. Microbiol. Immunol. 2001; 45: 59-262.
29. He F, Ouwehand AC, Isolauri E, Hashimoto H, Benno Y, and Salminen S. Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants. FEMS Immunol. Med. Microbiol. 2001; 30: 43-47.
30. He F, Ouwehand AC, Isolauri E, Hosoda M, Benno Y, and Salminen S. Differences in composition and mucosal adhesion of bifidobacteria isolated from healthy adults and healthy seniors. Curr. Microbiol. 2001; 43: 351-354.
31. Henriksson A, Szewzyk R, and Conway PL. Characteristics of the adhesive determinants of Lactobacillus fermentum 104. Appl. Environ. Microbiol. 1991; 57: 499-502.
32. Hood SK and Zottola EA. Effect of low pH on the ability of Lactobacillus acidophilus to survive and adhere to human intestinal cells. J. Food Sci. 1988; 53: 1514-1516.
33. Hynönen U, Westerlund-Wikström B, Palva A, and Korhonen TK. Identification by flagellum display of an epithelial cell-and fibronectin-binding function in the SlpA surface protein of Lactobacillus brevis. J. Bacteriol. 2002; 184: 3360-3367.
34. Ibnou-Zekri N, Blum S, Schiffrin EJ, and von der Weid T. Divergent patterns of colonization and immune response elicited from two intestinal Lactobacillus strains that display similar properties in vitro. Infect. Immun. 2003; 71: 428-436.
35. Jacobsen CN, Rosenfeldt Nielsen V, Hayford AE, Moller PL, Michaelsen KF, Paerregaard A, Sandstrom B, Tvede M, and Jakobsen M. Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by in vitro techniques and evaluation of the colonization ability of five selected strains in humans. Appl. Environ. Microbiol. 1999; 65: 4949-4956.
36. Jakava-Viljanen M and Palva A. Isolation of surface (S) layer protein carrying Lactobacillus species from porcine intestine and faeces and characterization of their adhesion properties to different host tissues.Vet. Microbiol. 2007, doi: 10.1016/j.vetmic. 2007.04.029.
37. Johansson ML Molin G, Jeppsson B, Nobaek S, Ahrne S, and Bengmark S. Administration of different Lactobacillus strains in fermented oatmeal soup: in vivo colonization of human intestinal mucosa and effect on the indigenous flora. Appl. Environ. Microbiol. 1993; 59: 15-20.
38. Juntunen M, Kirjavainen PV, OuwehandAC, Salminen SJ, and Isolauri E. Adherence of probiotic bacteria to human intestinal mucus in healthy infants and during rotavirus infection. Clin. Diagn. Lab. Immunol. 2001; 8: 293-296.
39. Kankaanpää P, Tuomola E, El-Nezami H, Ahokas J, and Salminen SJ. Binding of aflatoxin B1 alters the adhesion properties of Lactobacillus rhamnosus strain GG in a Caco-2 model. J. Food Prot. 2000; 63: 412-414.
40. Kapczynski DR, Meinersmann RJ, and Lee MD. Adherence of Lactobacillus to intestinal 407 cells in culture correlates with fibronectin binding. Curr. Microbiol. 2000; 41: 136-141.
41. Kirjavainen PV, Ouwehand AC, Isolauri E, and Salminen SJ. The ability of probiotic bacteria to bind to human intestinal mucus. FEMS Microbiol. Lett. 1998; 167: 185-189.
42. Klarin B, Johansson ML, Molin G, Larsson A, and Jeppsson B. Adhesion of the probiotic bacterium Lactobacillus plantarum 299v onto the gut mucosa in critically ill patients: a randomised open trial. Crit. Care 2005; 9: R285-R293.
43. Lahtinen SJ, Saarinen NM, Ämmälä J, Mäkelä SI, Salminen S, and Ouwehand AC. Interactions between lignans and probiotics. Microb. Ecol. Health Dis. 2002; 14: 106-109.
44. Larsen N, Nissen P, and Willats WG. The effect of calcium ions on adhesion and competitive exclusion of Lactobacillus ssp. and E. coli O138. Int. J. Food Microbiol. 2007; 114: 113-119.
45. Lehto EM and Salminen S. Adhesion of twelve different Lactobacillus strains to Caco-2 cell cultures. Nutr. Today 1996; 31(Suppl.): 49S-50S.
46. Matsumoto M, Tani H, Ono H, Ohishi H, and Benno Y. Adhesive property of Bifidobacterium lactis LKM512 and predominant bacteria of intestinal microflora to human intestinal mucin. Curr. Microbiol. 2002; 44: 212-215.
47. Miyoshi Y, Okada S, Uchimura T, and Satoh E. A mucus adhesion promoting protein, MapA, mediates the adhesion of Lactobacillus reuteri to Caco-2 human intestinal epithelial cells. Biosci. Biotechnol. Biochem. 2006; 70: 1622-1628.
48. Morelli L, Garbagna N, Rizzello F, Zonenschain D, and Grossi E. In vivo association to human colon of Lactobacillus paracasei B21060: map from biopsies. Digest. Liver Dis. 2006; 38: 894-898.
49. Morita H, He F, Fuse T, Ouwehand AC, Hashimoto H, Hosoda M, Mizumachi K, and Kurisaki J. Adhesion of lactic acid bacteria to Caco-2 cells and their effect on cytokine secretion. Microbiol. Immunol. 2002; 46: 293-297.
50. Op den Camp HJ, Oosterhof A, and Veerkamp JH. Interaction of bifidobacterial lipoteichoic acid with human intestinal epithelial cells. Infect. Immun. 1985; 47: 332-334.
51. Ouwehand A, Parhiala R, Salminen S, Rantala A, Huhtinen H, Sarparanta H, and Salminen E. Influence of the endogenous mucosal microbiota on the adhesion of probiotic bacteria in vitro. Microb. Ecol. Health Dis. 2004; 16: 202-204.
52. Ouwehand A, Tölkkö S, and Salminen S. The effect of digestive enzymes on the adhesion of probiotic bacteria in vitro. J. Food Sci. 2001; 66: 856-859.
53. Ouwehand AC, Isolauri E, Kirjavainen PV, and Salminen SJ. Adhesion of four Bifidobacterium strains to human intestinal mucus from subjects in different age groups. FEMS Microbiol. Lett. 1999; 172: 61-64.
54. Ouwehand AC, Isolauri E, Kirjavainen PV, Tolkko S, and Salminen SJ. The mucus binding of Bifidobacterium lactis Bb12 is enhanced in the presence of Lactobacillus GG and Lact. delbrueckii subsp. bulgaricus. Lett. Appl. Microbiol. 2000; 30: 10-13.
55. Ouwehand AC, Kirjavainen PV, Grönlund M-M, Isolauri E, and Salminen SJ. Adhesion of probiotic micro-organisms to intestinal mucus. Int. Dairy J. 1999; 9: 623-630.
56. Ouwehand AC, Niemi P, and Salminen SJ. The normal faecal microflora does not affect the adhesion of probiotic bacteria in vitro. FEMS Microbiol. Lett. 1999; 177: 35-38.
57. Ouwehand AC, Salminen S, Roberts PJ, Ovaska J, and Salminen E. Disease-dependent adhesion of lactic acid bacteria to the human intestinal mucosa. Clin. Diagn. Lab. Immunol. 2003; 10: 643-646.
58. Ouwehand AC, Salminen S, Tölkkö S, Roberts P, Ovaska J, and Salminen E. Resected human colonic tissue: newmodel for characterizing adhesion of lactic acid bacteria. Clin. Diagn. Lab. Immunol. 2002; 9: 184-186.
59. Ouwehand AC, Salminen S, Tölkkö S, Roberts PJ, Ovaska J, and Salminen E. Dependent adhesion of lactic acid bacteria to colonic tissue in vitro. Microecol. Ther. 2002; 29: 95-102.
60. Ouwehand AC, Tuomola EM, Tölkkö S, and Salminen S. Assessment of adhesion properties of novel probiotic strains to human intestinal mucus. Int. J. Food Microbiol. 2001; 64: 119-126.
61. Ouwehand AC, Tölkkö S, Kulmala J, Salminen S, and Salminen E. Adhesion of inactivated probiotic strains to intestinal mucus. Lett. Appl Microbiol. 2000; 31: 82-86.
62. Pretzer G, Snel J, Molenaar D, Wiersma A, Bron PA, Lambert J, de Vos WM, van der Meer R, Smits MA, and Kleerebezem M. Biodiversity-based identification and functional characterization of the mannose-specific adhesin of Lactobacillus plantarum. J. Bacteriol. 2005; 187: 6128-6136.
63. Resta-Lenert S, and Barrett KE. Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut 2003; 52: 988-997.
64. Riedel CU, Foata F, Goldstein DR, Blum S, and Eikmanns BJ. Interaction of bifidobacteria with Caco-2 cells-adhesion and impact on expression profiles. Int. J. Food Microbiol. 2006; 110: 62-68.
65. Rinkinen M, Westermarck E, Salminen S, and Ouwehand AC. Absence of host specificity for in vitro adhesion of probiotic lactic acid bacteria to intestinal mucus. Vet. Microbiol. 2003; 97: 55-61.
66. Rojas M, Ascencio F, and Conway PL. Purification and characterization of a surface protein from Lactobacillus fermentum 104R that binds to porcine small intestinal mucus and gastric mucin. Appl. Environ. Microbiol. 2002; 68: 2330-2336.
67. Roos S and Jonsson H. A high-molecular-mass cell-surface protein from Lactobacillus reuteri 1063 adheres to mucus components. Microbiology 2002; 148: 433-442.
68. Savage DC. Growth phase, cellular hydrophobicity, and adhesion in vitro of lactobacilli colonizing the keratinizing gastric epithelium in the mouse. Appl. Environ. Microbiol. 1992; 58: 1992-1995.
69. Sherman LA and Savage DC. Lipoteichoic acids in Lactobacillus strains that colonize the mouse gastric epithelium. Appl. Environ. Microbiol. 1986; 52: 302-304.
70. Tallon R, Arias S, Bressollier P, and Urdaci MC. Strain-and matrix-dependent adhesion of Lactobacillus plantarum is mediated by proteinaceous bacterial compounds. J. Appl. Microbiol. 2007; 102: 442-451.
71. Tuomola EM, Ouwehand AC, and Salminen SJ. Chemical, physical and enzymatic pretreatments of probiotic lactobacilli alter their adhesion to human intestinal mucus glycoproteins. Int. J. Food Microbiol. 2000; 60: 75-81.
72. Tuomola EM and Salminen SJ. Adhesion of some probiotic and dairy Lactobacillus strains to Caco-2 cell cultures. Int. J. Food Microbiol. 1998; 41: 45-51.
73. Walter J, Chagnaud P, Tannock GW, Loach DM, Dal Bello F, Jenkinson HF, Hammes WP, and Hertel C. A high-molecular-mass surface protein (Lsp) and methionine sulfoxide reductase B (MsrB) contribute to the ecological performance of Lactobacillus reuteri in the murine gut. Appl. Environ. Microbiol. 2005; 71: 979-986.
74. Vesterlund S, Paltta J, Karp M, and Ouwehand AC. Measurement of bacterial adhesion-in vitro evaluation of different methods. J. Microbiol. Methods 2005; 60: 225-233.
75. von Wright A, Vilpponen-Salmela T, Llopis MP, Collins K, Kiely B, Shanahan F, and Dunne C. The survival and colonic adhesion of Bifidobacterium infantis in patients with ulcerative colitis. Int. Dairy J. 2002; 12: 197-200.
76. Zarate G, Morata de Ambrosini V, Perez Chaia A, and Gonzalez S. Some factors affecting the adherence of probiotic Propionibacterium acidipropionici CRL 1198 to intestinal epithelial cells. Can. J. Microbiol. 2002; 48: 449-457.
77. Aissi EA, Lecocq M, Brassart C, and Buoquelet S. Adhesion of some Bifidobacteria strains to human enterocyte-like cells and binding to mucosal glycoproteins. Microb. Ecol. Health Dis. 2001; 13: 32-39.
78. Alander M, Satokari R, Korpela R, Saxelin M, Vilpponen-Salmela T, Mattila-Sandholm T, and von Wright A. Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption. Appl. Environ. Microbiol. 1999; 65: 351-354.
79. Bachrach G, Ianculovici C, Naor R, and Weiss EI. Fluorescence based measurements of Fusobacterium nucleatum co-aggregation and of fusobacterial attachment to mammalian cells. FEMS Microbiol. Lett. 2005; 248(2): 235-240.
80. Beachey EH. Bacterial adherence: adhesin-receptor interactions mediating the attachment of bacteria to mucosal surfaces. J. Infect. Dis. 1981; 143: 325-345.
81. Bernet MF, Brassart D, Nesser JR, and Servin AL. Adhesion of human bifidobacterial strains to cultured human intestinal epithelial cells and inhibition of enteropathogen-cell interactions. Appl. Environ. Microbiol. 1993; 59: 4121-4128.
82. Bibiloni R, Fedorak RN, Tannock GW, Madsen KL, Gionchetti P, Campieri M, De Simone C, and Sartor RB. VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am. J. Gastroenterol. 2005; 100(7): 1539-1546.
83. Bibiloni R, Perez PF, and de Antoni GL. Will a high adhering capacity in a probiotic strain guarantee exclusion of pathogens from intestinal epithelia? Anaerobe 1999; 5: 519-524.
84. Bibiloni R, Perez PF, Garrote GL, Disalvo EA, and De Antoni GL. Surface characterization and adhesive properties of bifidobacteria. Methods Enzymol. 2001; 336: 411-427.
85. Boris S, Suarez JE, and Barbes C. Characterization of the aggregation promoting factor from Lactobacillus gasseri, a vaginal isolate. J. Appl. Microbiol. 1997; 83(4): 413-420.
86. Camilleri M. Probiotics and irritable bowel syndrome: rationale, putative mechanisms, and evidence of clinical efficacy. J. Clin. Gastroenterol. 2006; 40(3): 264-269.
87. Canzi E, Guglielmetti S, Mora D, Tamagnini I, and Parini C. Conditions affecting cell surface properties of human intestinal bifidobacteria. Antonie van Leeuwenhoek 2005; 88 (3-4): 207-219.
88. Cesena C, Morelli L, Alander M, Siljander T, Tuomola E, Salminen S, Mattila-Sandholm T, Vilpponen-Salmela T, and Von Wright A. Lactobacillus crispatus and its nonaggregating mutant in human colonization trials. J. Dairy Sci. 2001; 84: 1001-1010.
89. Chouraqui JP, Van Egroo LD, and Fichot MC. Acidified milk formula supplemented with Bifidobacterium lactis: impact on infant diarrhea in residential care settings. J. Pediatr. Gastroenterol. Nutr. 2004; 38(3): 288-292.
90. Collado MC, Gueimonde M, Hernández M, Sanz Y, and Salminen S. Adhesion of selected Bifidobacterium strains to human intestinal mucus and its role in enteropathogen exclusion. J. Food Prot. 2005; 68(12): 2672-2678.
91. Collado MC, Hernández M, and Sanz Y. Production of bacteriocin-like inhibitory compounds by potentially probiotic bifidobacteria. J. Food Prot. 2005; 68(5): 1034-1040.
92. Collado MC, Meriluoto J, and Salminen S. Development of new probiotics by strains combination: is it possible to improve the adhesion to intestinal mucus? J. Dairy Sci. 2007; 90: 2710-2716.
93. Collado MC, Meriluoto J, and Salminen S. In vitro analysis of probiotic strains combinations to inhibit pathogen adhesion to human intestinal mucus. Food Res. Int. 2007; 40(5): 629-636.
94. Collado MC, Meriluoto J, and Salminen S. Interactions between pathogens and lactic acid bacteria: aggregation and coaggregation abilities. Eur. J. Food Res. Technol. 2008; 226(5): 1065-1073.
95. Collado MC, Meriluoto J, and Salminen S. Measurement of aggregation properties of probiotic strains with pathogens: in vitro evaluation of different methods. J. Microbiol. Methods 2007; 71(1): 71-74.
96. Collado MC, Meriluoto J, and Salminen S. Role of commercial probiotic strains against human pathogen adhesion to intestinal mucus. Lett. Appl. Microbiol. 2007; 45(4): 454-460.
97. Del Re B, Sgorbati B, Miglioli M, and Palenzona D. Adhesion, autoaggregation and hydrophobicity of 13 strains of Bifidobacterium longum. Lett. Appl. Microbiol. 2000; 31: 438-442.
98. Femia AP, Luceri C, Dolara P, Giannini A, Biggeri A, Salvadori M, Clune Y, Collins KJ, Paglierani M, and Caderni G. Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis 2002; 23(11): 1953-1960.
99. Fooks LJ, Fuller R, and Gibson GR. Prebiotics, probiotics and human gut microecology. Int. Dairy J. 1999; 9: 53-61.
100. Forestier C, De Champs C, Vatoux C, and Joly B. Probiotic activities of Lactobacillus casei rhamnosus: in vitro adherence to intestinal cells and antimicrobial properties. Res. Microbiol. 2001; 152: 167-173.
101. Freter M, Factors affecting the microecology of the gut. In: Fuller R editor. Probiotics. The Scientific Basis. Chapman and Hall, Glasgow, 1992, pp. 111-145.
102. Fujiwara S, Hashiba H, Hirota T, and Forstner JF. Inhibition of the binding of enterotoxigenic Escherichia coli Pb176 to human intestinal epithelial cell line HCT-8 by an extracellular protein fraction containing BIF of Bifidobacterium longum SBT2928: suggestive evidence of blocking of the binding receptor gangliotetraosylceramide on the cell surface. Int. J. Food Microbiol. 2001; 67: 97-106.
103. GagnonM, Kheadr EE, Le BlayG, and Fliss I. Invitro inhibition of Escherichia coliO157: H7 by bifidobacterial strains of human origin. Int. J. Food Microbiol. 2004; 92: 69-78.
104. Gaudier E, Michel C, Segain JP, Cherbut C, and Hoebler C. The VSL# 3 probiotic mixture modifies microflora but does not heal chronic dextran-sodium sulfate-induced colitis or reinforce the mucus barrier in mice. J. Nutr. 2005; 135(12): 2753-2761.
105. Gionchetti P, Amadini C, Rizzello F, Venturi A, and Campieri M. Review article: treatment of mild to moderate ulcerative colitis and pouchitis. Aliment. Pharmacol. Ther. 2002; 16(4): 13-19.
106. Gionchetti P, Lammers KM, Rizzello F, and Campieri M. VSL#3: an analysis of basic and clinical contributions in probiotic therapeutics. Gastroenterol. Clin. North Am. 2005; 34(3): 499-513.
107. Gomez Zavaglia A, Kociubinski G, Perez P, Disalvo E, and De Antoni G. Effect of bile on the lipid composition and surface properties of bifidobacteria. J. Appl. Microbiol. 2002; 93(5): 794-799.
108. Green JD and Klaenhammer TR. Factors involved in adherence of lactobacilli to human Caco-2 cells. Appl. Environ. Microbiol. 1994; 60: 4487-4494.
109. Guandalini S. Probiotics for children: use in diarrhea. J. Clin. Gastroenterol. 2006; 40(3): 244-248.
110. Gueimonde M, Jalonen L, He F, Hiramatsu M, and Salminen S. Adhesion and competitive inhibition and displacement of human enteropathogens by selected lactobacilli. Food Res. Int. 2006; 39(4): 467-471.
111. Gueimonde M, Noriega L, Margolles A, De los Reyes-Gavilan CG, and Salminen S. Ability of Bifidobacterium strains with acquired resistance to bile to adhere to human intestinal mucus. Int. J. Food Microbiol. 2005; 101: 341-346.
112. Handley PS, Harty DW, Wyatt JE, Brown CR, Doran JP, and GibbsAC.Acomparison of the adhesion, coaggregation and cell-surface hydrophobicity properties of fibrillar and fimbriate strains of Streptococcus salivarius. J. Gen. Microbiol. 1987; 133(11): 3207-3217.
113. Jankovic I, Ventura M, Meylan V, Rouvet M, Elli M, and Zink R. Contribution of aggregation-promoting factor to maintenance of cell shape in Lactobacillus gasseri 4B2. J. Bacteriol. 2003; 185: 3288-3296.
114. Juntunen M, Kirjavainen PV, Ouwehand AC, Salminen SJ, and Isolauri E. Adherence of probiotic bacteria to human intestinal mucus in healthy infants and during rotavirus infection. Clin. Diagn. Lab. Immunol. 2001; 8(2): 293-296.
115. Kajander K, Hatakka K, Poussa T, Farkkila M, and Korpela R. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention. Aliment. Pharmacol. Ther. 2005; 22(5): 387-394.
116. Katz JA. Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile diarrhea. J. Clin. Gastroenterol. 2006; 40(3): 249-255.
117. Kim HJ, Vazquez Roque MI, Camilleri M, Stephens D, Burton DD, Baxter K, Thomforde G, and Zinsmeister AR. A randomized controlled trial of a probiotic combination VSL#3 and placebo in irritable bowel syndrome with bloating. Neurogastroenterol. Motil. 2005; 17(5): 687-696.
118. Kirjavainen PE, Ouwehand AC, Isolauri E, and Salminen S. The ability of probiotic bacteria to bind to human intestinal mucus. FEMS Microbiol. Lett. 1998; 167: 185-189.
119. Kos B, Suskovic J, Vukovic S, Simpraga M, Frece J, and Matosic S. Adhesion and aggregation ability of probiotic strain Lactobacillus acidophilus M92. J. Appl. Microbiol. 2003; 94: 981-987.
120. Lee Y-J, Yu W-K, and Heo T-R. Identification and screening for antimicrobial activity against Clostridium difficile of Bifidobacterium and Lactobacillus species isolated from healthy infant faeces. Int. J. Antimicrob. Agents 2003; 21: 340-346.
121. Li J and Ellen RP. Coaggregation of Porphyromonas (Bacteroides) gingivalis, other species of bacteroides, and Actinomyces viscosus. Methodological evaluation. J. Microbiol. Methods 1990; 12: 91-96.
122. Malik A, Sakamoto M, Ono T, and Kakii K. Coaggregation between Acinetobacter johnsonii S35 and Microbacterium esteraromaticum strains isolated from sewage activated sludge. J. Biosci. Bioeng. 2003; 96: 10-15.
123. Myllyluoma E, Veijola L, Ahlroos T, Tynkkynen S, Kankuri E, Vapaatalo H, Rautelin H, and Korpela R. Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy-a placebo-controlled, double-blind randomized pilot study. Aliment. Pharmacol. Ther. 2005; 21(10): 1263-1272.
124. Nagayama M, Sato M, Yamaguchi R, Tokuda C, and Takeuchi H. Evaluation of coaggregation among Streptococcus mitis. Fusobacterium nucleatum and Porphyromonas gingivalis. Lett. Appl. Microbiol. 2001; 33(2): 122-125.
125. Olivares M, Díaz-Ropero MP, Gómez N, Lara-Villoslada F, Sierra S, Maldonado JA, Martín R, Rodríguez JM, and Xaus J. The consumption of two new probiotic strains, Lactobacillus gasseriCECT5714 and Lactobacillus coryniformis CECT5711, boosts the immune system of healthy humans. Int. Microbiol. 2006; 9(1): 47-52.
126. Ouwehand AC and Salminen S. In vitro adhesion assays for probiotics and their in vivo relevance: a review. Microbial Ecol. Health Dis. 2003; 15: 175-184.
127. Ouwehand AC, Isolauri E, Kirjavainen PV, and Salminen SJ. Adhesion of four Bifidobacterium strains to human intestinal mucus from subjects in different age groups. FEMS Microbiol. Lett. 1999; 172: 61-64.
128. Ouwehand AC, Isolauri E, Kirjavainen PV, Tolkko S, and Salminen SJ. The mucus binding of Bifidobacterium lactis Bb12 is enhanced in the presence of Lactobacillus GG and Lact. delbrueckii subsp. bulgaricus. Lett. Appl. Microbiol. 2000; 30(1): 10-13.
129. Ouwehand AC, Salminen S, and Isolauri E. Probiotics: an overviewof beneficial effects. Antonie van Leeuwenhoek 2002; 82: 279-289.
130. Pelletier C, Bouley C, Cayuela C, Bouttier S, Bourlioux P, and Bellon-Fontaine MN. Cell surface characteristics of Lactobacillus casei subsp. casei, Lactobacillus paracasei subsp. paracasei, and Lactobacillus rhamnosus strains. Appl. Environ. Microbiol. 1997; 63: 1725-1731.
131. Perdigón G, Maldonado Galdeano C, Valdez JC, and Medici M. Interaction of lactic acid bacteria with the gut immune system. Eur. J. Clin. Nutr. 2002; 56(4): S21-S26.
132. Peréz PF, Minnaard Y, Disalvo EA, and De Antoni GL. Surfaceproperties of bifidobacterial strains of human origin. Appl. Environ. Microbiol. 1998; 64: 21-26.
133. Reid G, McGroarty JA, Angotti R, and Cook RL. Lactobacillus inhibitor production against Escherichia coli and coaggregation ability with uropathogens. Can. J. Microbiol. 1988; 34: 344-351.
134. Rickard AH, Gilbert P, High NJ, Kolenbrander PE, and Handley PS. Bacterial coaggregation: an integral process in the development of multi-species biofilms. Trends Microbiol. 2003; 11: 94-100.
135. Rinkinen M, Westermarck E, Salminen S, and Ouwehand AC. Absence of host specificity for in vitro adhesion of probiotic lactic acid bacteria to intestinal mucus. Vet. Microbiol. 2003; 97: 55-61.
136. Rojas M and Conway PL. Colonization by lactobacilli of piglet small intestinal mucus. J. Appl. Bacteriol. 1996; 81: 474-480.
137. Roselli M, Finamore A, Britti MS, and Mengheri E. Probiotic bacteria Bifidobacterium animalis MB5 and Lactobacillus rhamnosus GG protect intestinal Caco-2 cells from the inflammation-associated response induced by enterotoxigenic Escherichia coli K88. Br. J. Nutr. 2006; 95(6): 1177-1184.
138. Ruas-Madiedo P, Gueimonde M, Margolles A, de los Reyes-Gavilan CG, and Salminen S. Exopolysaccharides produced by probiotic strains modify the adhesion of probiotics and enteropathogens to human intestinal mucus. J. Food Prot. 2006; 69(8): 2011-2015.
139. Schachtsiek M, Hammes WP, and Hertel C. Characterization of Lactobacillus coryniformis DSM 20001T surface protein Cpf mediating coaggregation with and aggregation among pathogens. Appl. Environ. Microbiol. 2004; 70(12): 7078-7085.
140. Schellenberg J, Smoragiewicz W, and Karska-Wysocki B. A rapid method combining immunofluorescence and flow cytometry for improved understanding of competitive interactions between lactic acid bacteria (LAB) and methicillin-resistant S. aureus (MRSA) in mixed culture. J. Microbiol. Methods 2006; 65(1): 1-9.
141. Servin AL. Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol. Rev. 2004; 28: 405-440.
142. Spencer RJ and Chesson A. The effect of Lactobacillus spp. on the attachment of enterotoxigenic Escherichia coli to isolated porcine enterocytes. J. Appl. Bacteriol. 1994; 77: 215-220.
143. Timmerman HM, Koning CJ, Mulder L, Rombouts FM, and Beynen AC. Monostrain, multistrain and multispecies probiotics-a comparison of functionality and efficacy. Int. J. Food Microbiol. 2004; 96: 219-233.
144. Toure R, Kheardr E, Lacroix C, Moroni O, and Fliss I. Production of antibacterial substances by bifidobacterial isolates from infant stool active against Listeria monocytogenes. J. Appl. Microbiol. 2003; 95: 1058-1069.
145. Tuomola EM, Ouwehand AC, and Salminen S. Chemical, physical and enzymatic pretreatments of probiotic lactobacilli alter their adhesion to human intestinal mucus glycoproteins. Int. J. Food Microbiol. 2000; 60: 75-81.
146. Vandevoorde L, Christiaens H, and Verstraete W. Prevalence of coaggregation among chicken lactobacilli. J. Appl. Bacteriol. 1992; 72: 214-219.
147. Vesterlund S, Paltta J, Karp M, and OuwehandAC. Measurement of bacterial adhesion-in vitro evaluation of different methods. J. Microbiol. Methods 2005; 60: 225-233.
148. Vinderola CG, Medici M, and Perdigón G. Relationship between interaction sites in the gut hydrophobicity, mucosal immunomodulating capacities and cell wall protein profiles in indigenous and exogenous bacteria. J. Appl. Bacteriol. 2004; 96: 230-243.
149. Wadström T, Anderson K, SydowM, Axelsson L, Lindgren S, and Gullmar B. Surface properties of lactobacilli isolated from the small intestine of pigs. J. Appl. Bacteriol. 1997; 62: 513-520.
150. Zoppi G, Cinquetti M, Benini A, Bonamini E, and Minelli EB. Modulation of the intestinal ecosystem by probiotics and lactulose in children during treatment with ceftriaxone. Curr. Ther. Res. 2001; 62: 418-435.
151. Alakomi HL, Skyttä E, Saarela M, Mattila-Sandholm T, Latva-Kala K, and Helander IM. Lactic acid permeabilizes Gram-negative bacteria by disrupting the outer membrane. Appl. Environ. Microbiol. 2000; 66: 2001-2005.
152. Arques JL, Fernandez J, Gaya P, Nunez M, Rodriguez E, and Medina M. Antimicrobial activity of reuterin in combination with nisin against food-borne pathogens. Int. J. Food Microbiol. 2004; 95: 225-229.
153. Axelsson LT, Chung TC, Dobrogosz WJ, and Lindgren SE. Production of a broad spectrum antimicrobial substance by Lactobacillus reuteri. Microb. Ecol. Health Dis. 1989; 2: 131-136.
154. Bauer R and Dicks LM. Mode of action of lipid II-targeting lantibiotics. Int. J. Food Microbiol. 2005; 101: 201-216.
155. Bernbom N, Licht TR, Brogren CH, Jelle B, Johansen AH, Badiola I, Vogensen FK, and Nørrung B. Effects of Lactococcus lactis on composition of intestinal microbiota: role of nisin. Appl. Environ. Microbiol. 2006; 72: 239-244.
156. Blom H and Mortvedt C. Anti-microbial substances produced by food associated microorganisms. Biochem. Soc. Trans. 1991; 19: 694-698.
157. Caplice E and Fitzgerald GF. Food fermentations: role of microorganisms in food production and preservation. Int. J. Food Microbiol. 1999; 50: 131-149.
158. Carlsson J, Iwami Y, and Yamada T. Hydrogen peroxide excretion by oral streptococci and effect of lactoperoxidase thiocyanate-hydrogen peroxide. Infect. Immun. 1983; 40: 70-80.
159. Chung TC, Axelsson LT, Lindgren SE, and Dobrogosz WJ. In vitro studies on reuterin synthesis by Lactobacillus reuteri. Microb. Ecol. Health Dis. 1989; 2: 137-144.
160. Cleveland J, Montville TJ, Nes IF, and Chikindas ML. Bacteriocins: safe, natural antimicrobials for food preservation. Int. J. Food Microbiol. 2001; 71: 1-20.
161. Condon S. Responses of lactic acid bacteria to oxygen. FEMS Microbiol. Rev. 1987; 46: 269-280.
162. Daniels JA, Krishnamurthi R, and SSH R. A review of the effects of carbon dioxide on microbial growth and food quality. J. Food Prot. 1985; 6: 532-537.
163. Dobrogosz WJ, Casas IA, Pagano GA, Talarico TL, Sjöberg B-M, and Karlsson M. Lactobacillus reuteri and the enteric microbiota. In: Gruff R, Midtvedt T, and Norin E, editors. The Regulatory and Protective Role of the Normal Microflora. Stockton Press, New York, 1989, pp. 283-292.
164. Dunne C, O'Mahony L, Murphy L, Thornton G, Morrissey D, O'Halloran S, Feeney M, Flynn S, Fitzgerald G, Daly C, Kiely B, O'Sullivan GC, Shanahan F, and Collins JK. In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings. Am. J. Clin. Nutr. 2001; 73: 386S-392S.
165. Eklund T. The antimicrobial effect of dissociated and undissociated sorbic acid at different pH levels. J. Appl. Bacteriol. 1983; 54: 383-389.
166. Eklund T. Organic acids, and esters. In: GouldGW, editor. Mechanisms of Action of Food Preservation Procedures. Elsevier, New York, 1989, pp. 161-200.
167. Eschenbach DA, Davick PR, Williams BL, Klebanoff SJ, Young-Smith K, Critchlow CM, and Holmes KK. Prevalence of hydrogen peroxide-producing Lactobacillus species in normalwomen andwomenwith bacterial vaginosis. J. Clin. Microbiol. 1989; 27: 251-256.
168. Héchard Yand Sahl HG. Mode of action of modified and unmodified bacteriocins from Gram-positive bacteria. Biochimie 2002; 84: 545-557.
169. Jay JM.Antimicrobial properties of diacetyl. Appl. Environ.Microbiol. 1982; 44: 525-532.
170. Kamau DN, Doores S, and Pruitt K. Enhanced thermal destruction of Listeria monocytogenes and Staphylococcus aureus by the lactoperoxidase system. Appl. Environ. Microbiol. 1990; 56: 2711-2716.
171. Klaenhammer TR. Genetics of bacteriocins produced by lactic acid bacteria. FEMS Microbiol. Rev. 1993; 12: 39-85.
172. Klebanoff SJ, Hillier SL, Eschenbach DA, and Waltersdorph AM. Control of the microbial flora of the vagina by H2O2-generating lactobacilli. J. Infect. Dis. 1991; 164: 94-100.
173. Lindgren SE and Dobrogosz WJ. Antagonistic activities of lactic acid bacteria in food and feed fermentations. FEMS Microbiol. Rev. 1990; 87: 149-163.
174. Metchnikoff E. The Prolongation of Life. Optimistic Studies. Butterworth-Heinemann, London, 1907.
175. Reid G and Burton J. Use of Lactobacillus to prevent infection by pathogenic bacteria. Microbes Infect. 2002; 4: 319-324.
176. Ryan CS and Kleinberg I. Bacteria in human mouths involved in the production and utilization of hydrogen peroxide. Arch. Oral Biol. 1995; 40: 753-763.
177. St, Amant DC, Valentin-Bon IE, and Jerse AE. Inhibition of Neisseria gonorrhoeae by Lactobacillus species that are commonly isolated from the female genital tract. Infect. Immun. 2002; 70: 7169-7171.
178. Talarico TL and Dobrogosz WJ. Chemical characterization of an antimicrobial substance produced by Lactobacillus reuteri. Antimicrob. Agents Chemother. 1989; 33: 674-679.
179. Tamime AY. Fermented milks: a historical food with modern applications-a review. Eur. J. Clin. Nutr. 2002; 56(Suppl. 4): S2-S15.
180. Alander M, Satokari R, Korpela R, et al. Persistence of colonization of human colonic mucosa by Lactobacillus rhamnosus GG, after oral consumption. Appl. Environ. Microbiol. 1999; 65: 351-354.
181. Benno Y, He F, and Hosoda M. Effects of Lactobacillus GG yoghurt on human intestinal microecology in Japanese subjects. Nutr. Today 1996; 31: 9S-11S.
182. Bjorksten B, Sepp E, Julge K, Voor T, and Mikelsaar M. Allergy development and the intestinal microflora during the first year of life. J. Allergy Clin. Immunol. 2001; 108(4): 516-520.
183. Carmody RJ and Chen YH. Nuclear factor-kappaB: activation and regulation during tolllike receptor signaling. Cell. Mol. Immunol. 2007; 4(1): 31-41.
184. Christensen HR, Frokiaer H, and Pestka JJ. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J. Immunol. 2002; 168(1): 171-178.
185. Di Giacinto C, Marinaro M, Sanchez M, Strober W, and Boirivant M. Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells. J. Immunol. 2005; 174(6): 3237-3246.
186. Franchi L, McDonald C, Kanneganti TD, Amer A, and Nunez G. Nucleotide-binding oligomerization domain-like receptors: intracellular pattern recognition molecules for pathogen detection and host defense. J. Immunol. 2006; 177(6): 3507-3513.
187. Goldin BR, Gorbach SL, Saxelin M, Barakat S, Gualtieri L, and Salminen S. Survival of Lactobacillus species (strain GG) in human gastrointestinal tract. Digest. Dis. Sci. 1992; 37(1): 121-128.
188. Harmsen HJ, Wildeboer-Veloo AC, Raangs GC, Wagendorp AA, Klijn N, Bindels JG, et al. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J. Pediatr. Gastroenterol. Nutr. 2000; 30(1): 61-67.
189. Hart AL, et al. Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 2004; 53(11): 1602-1609.
190. He F, Morita H, Hashimoto H, et al. Intestinal Bifidobacterium species induce varying cytokine production. J. Allergy Clin. Immunol. 2002; 109: 1035-1036.
191. He F, Tuomola E, Arvilommi H, and Salminen S. Modulation of humoral immune response through probiotic intake. FEMS Immunol. Med. Microbiol. 2000; 29: 47-52.
192. Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, and Gordon JI. Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001; 291 (5505): 881-884.
193. Isolauri E, Arvola T, Sutas Y, Moilanen E, and Salminen S. Probiotics in the management of atopic eczema. Clin. Exp. Allergy 2000; 30(11): 1604-1610.
194. Isolauri E, Joensuu J, Suomalainen H, Luomala M, and Vesikari T. Improved immunogenicity of oral D _ RRV reassortant rotavirus vaccine by Lactobacillus casei GG. Vaccine 1995; 13: 310-312.
195. Isolauri E, Majamaa H, Arvola T, Rantala I, Virtanen E, and Arvilommi H. Lactobacillus casei strain GG reverses increased intestinal permeability induced by cow milk in suckling rats. Gastroenterology 1993; 105: 1643-1650.
196. Kaila M, Isolauri E, Salminen S, Mikelsaar M, and Sepp E. Colonisation of infants with Lactobacillus GG during acute rotavirus diarrhea. Biosci. Microflora 1998; 17: 149-151.
197. Kalliomäki MA and Walker WA. Physiologic and pathologic interactions of bacteria with gastrointestinal epithelium. Gastroenterol. Clin. North Am. 2005; 34: 383-399.
198. Kirjavainen PV, Salminen SJ, and Isolauri E. Probiotic bacteria in the management of atopic disease: underscoring the importance of viability. J. Pediatr. Gastroenterol. Nutr. 2003; 36: 223-227.
199. Kukkonen K, Nieminen T, Poussa T, Savilahti E, and Kuitunen M. Effect of probiotics on vaccine antibody responses in infancy-a randomized placebo-controlled doubleblind trial. Pediatr. Allergy Immunol. 2006; 17(6): 416-421.
200. Lammers KM, et al. Effect of probiotic strains on interleukin 8 production by HT29/19A cells. Am. J Gastroenterol. 2002; 97(5): 1182-1186.
201. Maassen CB, et al. Orally administered Lactobacillus strains differentially affect the direction and efficacy of the immune response. Vet. Q. 1998; 20(Suppl. 3): S81-S83.
202. Majamaa H, Isolauri E, Saxelin M, and Vesikari T. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J. Pediatr. Gastroenterol. Nutr. 1995; 20 (3): 333-338.
203. Matsuzaki T, et al. Prevention of onset in an insulin-dependent diabetes mellitus model, NOD mice, by oral feeding of Lactobacillus casei. Acta Pathol. Microbiol. Immunol. Scand. 1997; 105(8): 643-649.
204. Mullie C, Yazourh A, Thibault H, et al. Increased poliovirus-specific intestinal antibody response coincides with promotion of Bifidobacterium longum-infantis and Bifidobacterium breve in infants: a randomized, double-blind, placebo-controlled trial. Pediatr. Res. 2004; 56(5): 791-795.
205. Neish AS, Gewirtz AT, Zeng H, et al. Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science 2000; 289(5484): 1560-1563.
206. Neish AS. Bacterial inhibition of eukaryotic pro-inflammatory pathways. Immunol. Res. 2004; 29(1-3): 175-186.
207. Pessi T, Sutas Y, Hurme M, and Isolauri E. Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin. Exp. Allergy 2000; 30(12): 1804-1808.
208. Pohjavuori E, et al. Lactobacillus GG effect in increasing IFN-gamma production in infants with cow's milk allergy. J. Allergy Clin. Immunol. 2004; 114(1): 131-136.
209. Rautava S, Kalliomaki M, and Isolauri E. Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J. Allergy Clin. Immunol. 2002; 109: 119-121.
210. Ruiz PA, et al. Innate mechanisms for Bifidobacterium lactis to activate transient proinflammatory host responses in intestinal epithelial cells after the colonization of germfree rats. Immunology 2005; 115(4): 441-450.
211. Sepp E, Mikelsaar M, and Salminen S. Effect of Lactobacillus casei strain GG administration on the gastrointestinal microbiota of newborns. Microb. Ecol. Health Dis. 1993; 6: 309-314.
212. Sheil B, McCarthy J, O'Mahony L, et al. Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis. Gut 2004; 53(5): 694-700.
213. Sturm A, Rilling K, Baumgart DC, et al. Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signaling. Infect. Immun. 2005; 73(3): 1452-1465.
214. Sudo N, Sawamura S, et al. The requirement of intestinal bacterial flora for the development of an IgE production system susceptible to oral tolerance induction. J. Immunol. 1997; 159: 1739-1745.
215. Takeda K and Akira S. Toll-like receptors in innate immunity. Int. Immunol. 2005; 17: 1-14.
216. Viljanen M, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, Tuure T, and Kuitunen M. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double blind placebo-controlled trial. Allergy 2004, doi:10.1111/j.1398-9995.
217. von der Weid T, Bulliard C, and Schiffrin EJ. Induction by a lactic acid bacterium of a population of CD4({thorn}) T cells with low proliferative capacity that produce transforming growth factor beta and interleukin-10. Clin. Diagn. Lab. Immunol. 2001; 8(4): 695-701.
218. Benno Yand Mitsuoka T. Development of intestinal microflora in humans and animals. Bifidobacteria Microfi. 1986; 5: 13-25.
219. Collado MC, Derrien M, Isolauri E, de Vos WM, and Salminen S. Intestinal integrity and Akkermansia muciniphila: a mucin-degrading member of the intestinal microbiota present in infants, adults and the elderly. Appl. Environ. Microbiol. 2007, doi:10.1128/AEM.01477-07.
220. Gore C, Munro K, Lay C, Bibiloni R, Morris J, Woodstock A, Custovic A, and Tannock GW, Bifidobacterium pseudocatenulatum is associated with atopic eczema: a nested case-control study investigating the fecal microbiota of infants. J. Allergy Clin. Immunol., 2008; 121: 135-140.
221. Grönlund MM, Gueimonde M, Laitinen K, Kociubinski G, Salminen S, and Isolauri E. Maternal breast-milk and intestinal bifidobacteria guide the compositional development of the Bifidobacterium microbiota in infants at risk of allergic disease. Clin. Exp. Allergy 2007, doi:10.1111/j.1365-2222.2007.02849.x.
222. Guarner F and Malagelada JR. Gut flora in health and disease. Lancet 2003; 361: 512-519.
223. Guerin-Danan C, Meslin JC, Chambard A, Charpilienne A, Relano P, Bouley C, Cohen J, and Andrieux C. Food supplementation with milk fermented by Lactobacills casei DN-114 001 protects suckling rats from rotavirus-associated diarrhea. J. Nutr. 2001; 131: 111-117.
224. Gueimonde M, Sakato S, Kalliomäki M, Isolauri E, Benno Y, and Salminen S. Effect of maternal consumption of Lactobacillus GG on transfer and establishment of fecal bifidobacterial microbiota in neonates. J. Pediatr. Gastroenterol. Nutr. 2006; 42: 166-170.
225. Harmsen HJ, Wildeboer Veloo AC, Raangs GC, Wagendorp AA, Klijn N, Bindels JG, and Welling GW. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J. Pediatr. Gastroenterol. Nutr. 2000; 30: 61-67.
226. He F, Morita H, Hashimoto H, Hosoda M, Kurisaki J, OuwehandAC, Isolauri E, Benno Y, and Salminen S. Intestinal Bifidobacterium species induce varying cytokine production. J. Allergy Clin. Immunol. 2002; 109: 1035-1036.
227. He F, Morita H, Kubota A, Ouwehand AC, Hosoda M, Hiramatsu M, and Kurisaki J. Effect of orally administered non-viable Lactobacillus cells on murine humoral immune responses. Microbiol. Immunol. 2005; 49: 993-997.
228. Hebuterne X. Gut changes attributed to ageing: effects on intestinal microflora. Curr. Opin. Clin. Nutr. Metab. Care 2003; 6: 49-54.
229. Hopkins MJ, Sharp R, and Macfarlane GT. Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles. Gut 2001; 48: 198-205.
230. Hopkins MJ and Macfarlane GT. Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection. J. Med. Microbiol. 2002; 51: 448-454.
231. Juntunen M, Kirjavainen P, Ouwehand AC, Salminen SJ, and Isolauri E. Gut microflora changes and probiotics in children in day care centers. Biosci. Microflora 2003; 22: 99-107.
232. Kalliomäki M, Kirjavainen P, Eerola E, et al. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J. Allergy Clin. Immunol. 2001; 107: 129-134.
233. Kirjavainen PV, Apostolou E, Arvola T, Salminen SJ, Gibson GR, and Isolauri E. Characterizing the composition of intestinal microflora as a prospective treatment target in infant allergic disease. FEMS Immunol. Med. Microbiol. 2001; 32: 1-7.
234. Kirjavainen PV, Arvola T, Salminen SJ, and Isolauri E. Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning? Gut 2002; 51: 51-55.
235. Kleessen B, Bunke H, Tovar K, Noack J, and Sawatzki G. Influence of two infant formulas and human milk on the development of the faecal flora in newborn infants. Acta Pediatr. 1995; 84: 1347-1356.
236. Mackie RI, Sghir A, and Gaskins HR. Developmental microbial ecology of the neonatal gastrointestinal tract. Am. J. Clin. Nutr. 1999; 69(Suppl.): 1035S-1045S.
237. Martin R, Heilig HGHJ, Zoetendal EG, Jimenez E, Fernandez L, Smidt H, and Rodriguez JM. Cultivation-independent assessment of the bacterial diversity of breast milk among healthy women. Res. Microbiol. 2007; 158: 31-37.
238. Mikelsaar M, Mändar R, Sepp E, and Annuk H, Human lactic acid microflora and its role in the welfare of host. In: Salminen S, von Wright A, Ouwehand A, editors. Lactic Acid Bacteria. Marcel Dekker Inc., New York, 2004.
239. Mitsuoka T and Hayakawa K. Die faecalflora bei Menschen I. Mitteilung: die zusammensetzung der faecalflora der verschiedenen altersgruppen. ZBL Bakt. Hyg. 1972; 233: 333-42.
240. Morelli LC, Cesena C, de Haën, and Gozzini L. Taxonomic Lactobacillus composition of feces from human newborns during the first few days. Microb. Ecol. 1998; 35: 205-212.
241. OuwehandAC, Isolauri E, He F, Hashimoto H, BennoY, and Salminen S. Differences in Bifidobacterium flora composition in allergic and healthy infants. J. Allergy Clin. Immunol. 2001; 108: 144-145.
242. Ouwehand A, Isolauri E, and Salminen S. The role of the intestinal microflora for the development of the immune system in early childhood. Eur. J. Nutr. 2002; 41(Suppl. 1): I32-I37.
243. Palmer C, Bik EM, DiGiulio DB, Relman DA, and Brown PO. Development of the human infant intestinal microbiota. PLoS Biol. 2007; 5(7): e177.
244. Penders J, Thijs C, Vink C, Stelma FF, Snijders B, Kummeling I, van den Brandt PA, and Stobberingh EE. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 2006; 118: 511-521.
245. Penders J, Thijs C, van den Brandt PA, Kummeling I, Snijders B, Stelma F, Adams H, van Ree R, and Stobberingh EE. Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut 2007; 56: 661-667.
246. Rajilic-Stojanovic M, Smidt H, and de Vos WM. Diversity of the human gastrointestional tract microbiota revisited. Environ. Microbiol. 2007; 9: 2125-2136.
247. Rinne M, Gueimonde M, Kalliomäki M, Hoppu U, Salminen S, and Isolauri E. Similar bifidogenic effects of prebiotic-supplemented partially hydrolyzed infant formula and breastfeeding on infant gut microbiota. FEMS Immunol. Med. Microbiol. 2005; 43: 59-65.
248. Salminen S, Bouley C, Boutron-Ruault MC, et al. Gastrointestinal physiology and function-targets for functional food development. Br. J. Nutr. 1998; 80(Suppl.): 147-171.
249. Satokari RM, Vaughan EE, Favier CF, Dore J, Edwards C, and de VosWM. Diversity of Bifidobacterium and Lactobacillus spp. in breast-fed and formula-fed infants as assessed by 16S rDNA sequence differences. Microb. Ecol. Health Dis. 2002; 14: 97-105.
250. Satokari RM, Vaughan EE, Smidt H, Saarela M, Mättö J, and de Vos WM. Molecular approaches for the detection and identification of bifidobacteria and lactobacilli in the human gastrointestinal tract. Syst. Appl. Microbiol. 2003; 26: 572-584.
251. Schultz M, Gottl C, Young RJ, Iwen P, and Vanderhoof JA. Administration of oral probiotic bacteria to pregnant women causes temporary infantile colonization. J. Pediatr. Gastroenterol. Nutr. 2004; 38: 293-297.
252. Song Y, Liu C, and Finegold SM. Real-time PCR quantitation of clostridia in feces of autistic children. Appl. Environ. Microbiol. 2004; 70: 6459-6465.
253. Stark PL and Lee A. The microbial ecology of the large bowel of breast-fed and formulafed infants during the first year of life. J. Med. Microbiol. 1982 189-203.
254. Stsepetova J, Sepp E, Julge K, Vaughan E, Mikelsaar M, and de Vos WM. Molecularly assessed shifts of Bifidobacterium ssp. and less diverse microbial communities are characteristic of 5-year-old allergic children. FEMS Immunol. Med. Microbiol. 2007; 51: 260-269.
255. Wang M, Ahrne S, Antonsson M, and Molin G. T-RFLP combined with principal components analysis and 16S rRNA sequencing: an effective strategy for comparison of fecal microbiota in infants of different ages. J. Microbiol. Methods 2004; 59: 53-69.
256. Woodcock A, Moradi M, Smillie FI, Murray CS, Burnie JP, and Custovic A. Clostridium difficile, atopy and wheeze during the first year of life. Pediatr. Allergy Immunol. 2002; 13 (5): 357-360.
257. Woodmansey EJ. Intestinal bacteria and ageing. J. Appl. Microbiol. 2007; 102: 1178-1186.
258. Alexa P, Hamrik J, Stouracova K, and Salajka E. Oral immunization against enterotoxigenic colibacillosis in weaned piglets by non-pathogenic E. coli strain with K88 (F4) colonizing factors. Vet. Med. Czech. 2005; 50: 315-320.
259. Anjum M, Tucker J, Sprigings K, Woodward M, and Ehricht R. Use of miniaturized protein arrays for E. coli O serotyping. Clin. Vaccine Immunol. 2006; 13: 561-567.
260. America Public Health Association (APHA), Standard Methods for the Examination of Water and Wastewater, 20th ed. APHA, Washington, DC, 1998.
261. Ballmer K, Korczak B, Kuhnert P, Slickers P, Ehricht R, and Hachler H. Fast DNA serotyping of E. coli by use of an oligonucleotide microarray. J. Clin. Microbiol. 2007; 45: 370-379.
262. Beale L, Njuguna P, Chapman T, Al-Jassim R, Trott D, and Chin JC. Fitness genes of commensal and enterotoxigenic E. coli. In: Paterson JE, editor. Manipulating Pig Production XI. Australasian Pig Science Association Book Publication, Australia, 2007, pp. 193.
263. BertschingerHW, EngV, andWegmann P. Relationship between coliform contamination of floor and teats and the incidence of puerperal mastitis in two types of farrowing accommodations. In: Eskesbo I, editor. Proceedings of the Sixth International Congress on Animal Hygiene. Swedish University of Agricultural Science, Skara, Sweden, 1988, pp. 86-88.
264. Bielaszewska M, Dobrindt U, Gartner J, Gallitz I, Hacker J, Karch H, Muller D, Schubert S, Schmidt M, Sorsa L, and Zdziarski J. Aspects of genome plasticity in pathogenic E. coli. Int. J. Med. Microbiol. 2007, .
265. Blanco M, Lazo L, Blanco J, Dahbi G, Mora A, Lopez C, Gonzalez E, and Blanco J. Serotypes, virulence genes, and PFGE patterns of enteropathogenic E. coli isolated from Cuban pigs with diarrhea. Int. Microbiol. 2006; 9: 53-60.
266. Boudry G, Peron V, Le Huerou-Luron I, Lalles J, and Seve B. Weaning induces both transient and long-lasting modifications of absorptive, secretory and barrier properties of piglet intestine. J. Nutr. 2004; 134: 2256-2262.
267. Bruininx E, Binnendijk G, Van der Peet-Schwering C, Schrama J, Den Hartog L, Everts H, and Beynen A. Effect of creep feed consumption on individual feed intake characteristics and performance of group-housed weanling pigs. J. Anim. Sci. 2002; 80: 1413-1418.
268. Carroll J, Touchette K, Matteri B, Dyer C, and Allee G. Effect of spray-dried plasma and lipopolysaccharide exposure on weaned pigs. II. Effects on the hypothalamic-pituitary-adrenal axis of weaned pigs. J. Anim. Sci. 2002; 80: 502-509.
269. Chapman T, Smith AM, Daniels P, Jordan D, Trott D, and Chin JC. Phenotyping Escherichia coli antimicrobial resistances in pigs. In: Paterson JE, editor. Manipulating Pig Production XI. Australasian Pig Science Association, Book Publication, Australia, 2007, pp. 194.
270. Chapman T, Wu XY, Barchia I, Bettelheim K, Driesen S, Trott D, Wilson M, and Chin J. Comparison of virulence gene profiles of E. coli strains isolated from healthy and diarrheic swine. Appl. Environ. Microbiol. 2006; 72: 4782-4795.
271. Chin JC, Chapman TA. Turner B, andWuZY.Are-appraisal of early signaling events and gene activation in a human intestinal epithelial cell line in vitro by probiotics and enteric pathogenic bacteria species. Int. J. Probiotics Prebiotics, in press.
272. Chin JC and Mullbacher A, Immune activation versus hyporesponsiveness and tolerance in the gut: is there a role for probiotics in shaping an unbalanced response against commensals and pathogens? In: Fuller DR and Perdigon G, editors. Gut Flora, Nutrition and Health. Blackwell Science Ltd., 2002, pp. 178-200.
273. Correa MG and Marin J. O-serogroups, eae gene and EAF plasmid in E. coli isolates from cases of bovine mastitis in Brazil. Vet. Microbiol. 2002; 85: 125-132.
274. Crespi B. The evolution of social behavior in microorganisms. Trends Ecol. Evol. 2001; 16: 178-181.
275. Diez-Gonzalez F, Applications of bacteriocins in livestock. Curr. Iss. Intest. Microbiol. 2005; 8: 15-24.
276. Dixit S, Gordon D, WuXY, Chapman T, Kailasapathy K, and Chin J. Diversity analysis of commensal porcine E. coli -associations between genotypes and habitat in the porcine gastrointestinal tract. Microbiology 2004; 150: 1735-1740.
277. Dixon B. Antibiotics as growth promoters: risks and alternatives. ASM News 2000; 66(No. 5)
278. Fuller R. Probiotics in man and animals. J. Appl. Bacteriol. 1989; 66: 365-378.
279. Germon P, Roche D, Melo S, Mignon-Grasteau S, Dobrindt U, Hacker J, Schouler C, and Moulin-Schouleur M. tENA locus polymorphism and ecto-chromosomal DNA insertion hotspots are related to the phylogenetic group of E. coli strains. Microbiology 2007; 153: 826-837.
280. Janion C, Sikora (nee W_ojcik) A, Nowosielska A, and Grzesiuk E. SOS response in starved E. coli. Environ. Mol. Mutagen. 2002; 40: 129-133.
281. Jordan D, Chin J, Trott D, Antimicrobial use in the Australian pig industry: which drugs, howoften and why. In: Paterson JE, editor. Manipulating Pig Production XI. Australasian Pig Science Association Book Publication, Australia, 2007, pp. 122.
282. Katouli M, Lund A, Wallgren P, Kuhn I, Soderlind O, and Mollby R. Phenotypic characterization of intestinal E. coli of pigs during suckling, postweaning and fattening periods. Appl. Environ. Microbiol. 1995; 61: 778-783.
283. Kuhn L, Tullus K, and Molby R. Colonization and persistence of E. coli phenotypes in intestines of children aged 0-18 months. Infection 1986; 14: 7-12.
284. Kunin C and Beard M. Serological studies of O antigens of E. coli by means of the hemagglutination test. J. Bacteriol. 1963; 85: 541-548.
285. Kyriakis S, Tsiloyiannis V, Vlemmas J, Sarris K, Tsinas A, Alexopoulos C, and Jansegers L. The effect of probiotic LSP 122 on the control of post-weaning diarrhea syndrome of piglets. Res. Vet. Sci. 1999; 67: 223-228.
286. Lacher D, Strinsland H, Blank T, DonnenbergM, and Whittam T. Molecular evolution of typical EPEC: clonal analysis by multilocus sequence typing and virulence gene allelic profiling. J. Bacteriol. 2007; 189: 342-350.
287. Manner K and Spieler A. Probiotics in piglets-an alternative to traditional growth promoters. Microecol. Ther. 1997; 26: 243-256.
288. Miller G, Algozin K, McNamara P, and Bush E. Productivity and economic effects of antibiotics used for growth promotion in U.S. pork production. J. Agric. Appl. Econ. 2003; 35: 469-482.
289. Moeser A, Klok C, Ryan K, Wooten J, Little D, Cook V, and Blikslager A. Stress signaling pathways activated by weaning mediate intestinal dysfunction in the pig. Am. J. Physiol. Gastrointest. Liver Physiol. 2007; 292: 173-181.
290. Naomani B, Fairbrother J, and Gyles C.Virulence genes of O149 enterotoxigenic E. coli from outbreaks of postweaning diarrhea in pigs. Vet. Microiobiol. 2003; 97: 87-101.
291. Njuguna P. Studies on themanipulation of gastrointestinal tract bacteria.MSc. thesis, 2005, http://www.library.uow.edu.au/adt-NWU/public/adt-NWU20060719.125402/index.html.
292. Parker RB. Probiotics: the other half of the antibiotic story. Anim. Nutr. Health 1974; 29: 4-8.
293. Patterson J, Chapman T, Hegedus E, Barchia I, and Chin J. Selected culturable enteric bacterial populations are modified by diet acidification and the growth promotant tylosin. Letts. Appl. Microbiol. 2005; 41: 119-124.
294. Patterson J, Chandrasekara A, Bao S, Hegedus E, Caterson I, Denyer G, Turner B, Mullbacher A, Chin JC,Prebiotic supplementation with resistant starch alters health indices associated with metabolic changes and intestinal dysbiosis. Int. J. Probiotics Prebiotics, in press.
295. Sansom BF and Gleed PT. The ingestion of sow's faeces by suckling piglets. Br. J. Nutr. 1981; 46: 451-456.
296. Scaletsky I, Michalski J, Torres A, Dulguer M, and Kaper J. Identification and characterization of the locus for diffuse adherence, which encodes a novel afimbrial adhesin found in atypical EPEC. Infect. Immun. 2005; 73: 4753-4765.
297. Schierack P, Steinruck H, Kleta S, andVahjenW.Virulence factor gene profiles of E. coli isolates from clinically healthy pigs. Appl. Environ. Microbiol. 2006; 72: 6680-6686.
298. Simon O, Jadamus A, and Vahjen W. Probiotic feed additives -Effectiveness and expected modes of action. J. Anim. Feed Sci. 2001; 10: 51-67.
299. Smith MG, Chapman TA, Jordan D, Chin JC, and Trott D. Resistant phenotypes of enteric microbial communities from Australian pig farms. In: Paterson JE, editor. Manipulating Pig Production XI. Australasian Pig Science Association Book Publication, 2007, pp. 121.
300. Srinivasan U, Zhang L, France A, Ghosh D, ShalabyW, Xie J, Marrs C, and Foxman B. Probe hybridization array typing: a binary typing method for E. coli. J. Clin. Microbiol. 2007; 45: 206-214.
301. Stahl CH, Callaway TR, Lincoln L, Lonergan S, and Genovese K. Inhibitory activities of colicins against E. coli strains responsible for postweaning diarrhea and edema disease in swine. Antimicrob. Agents Chemother. 2004; 48: 3119-3121.
302. Taras D, Vahjen W, Macha M, and Simon O. Performance, diarrhea incidence, and occurrence of E. coli virulence genes during long-term administration of a probiotic Enterococcus faecium strain to sows and piglets. J. Anim. Sci. 2006; 84: 608-607.
303. U.S. Department of Agriculture. Reference of swine health and management in the United States. 2002. N338.0801. National Animal Health Monitoring System, Fort Collins, CO, 2001.
304. Van Belkum M and Stiles ME. Nonlantibiotic antibacterial peptides from lactic acid bacteria. Nat. Prod. Rep. 2000; 17: 323-335.
305. Welch R, Burland V, Plunkett IIIG, Redford P, Roesch P, Rasko D, Buckles E, Liou S, Boutin A, Hackett J, Stroud D, Mayhew G, Rose D, Zhou S, Schwartz D, Perna N, Mobley H, Donnenberg M, and Blattner F. Extensive mosaic structure revealed by the complete genome sequence of uropathogenic E. coli. Proc. Natl. Acad. Sci. USA 2002; 99: 17020-17024.
306. World Health Organization. Global principles for the containment of antimicrobial resistance in animals intended for food, 2000, http://www.who.int/cmc-documents/ zoonoses/docs/whocdscsraph2004.pdf.
307. Wu XY, Chapman TA, Trott DJ, Bettelheim KA, Do TN, Driesen S, Walker MJ, and Chin JC. Comparative analysis of virulence genes, genetic diversity and phylogeny between commensal and enterotoxigenic Escherichia coli from weaned pigs. Appl. Environ. Microbiol. 2007; 73: 83-91.
308. www.thepigsite.com/pighealth/article/227/farrowing-house-design